1/27
08:04 am
vtvt
vTv Therapeutics (NASDAQ:VTVT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $49.00 price target on the stock, up previously from $40.00.
Low
Report
vTv Therapeutics (NASDAQ:VTVT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $49.00 price target on the stock, up previously from $40.00.
1/27
06:06 am
vtvt
Rating for VTVT
Low
Report
Rating for VTVT
1/23
04:45 am
vtvt
Rating for VTVT
Low
Report
Rating for VTVT
1/23
04:45 am
vtvt
Rating for VTVT
Low
Report
Rating for VTVT
1/22
04:07 pm
vtvt
vTv Therapeutics initiated with a Buy at Roth Capital
Medium
Report
vTv Therapeutics initiated with a Buy at Roth Capital
1/22
04:07 pm
vtvt
vTv Therapeutics initiated with a Buy at Roth Capital
Medium
Report
vTv Therapeutics initiated with a Buy at Roth Capital
12/19
09:09 am
vtvt
vTv Therapeutics (NASDAQ:VTVT) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
vTv Therapeutics (NASDAQ:VTVT) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/20
06:03 am
vtvt
vTv Therapeutics (NASDAQ:VTVT) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
Low
Report
vTv Therapeutics (NASDAQ:VTVT) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
11/19
08:07 am
vtvt
vTv Therapeutics (NASDAQ:VTVT) is now covered by analysts at BTIG Research. They set a "buy" rating and a $40.00 price target on the stock.
Medium
Report
vTv Therapeutics (NASDAQ:VTVT) is now covered by analysts at BTIG Research. They set a "buy" rating and a $40.00 price target on the stock.
11/19
05:17 am
vtvt
Rating for VTVT
Medium
Report
Rating for VTVT
11/18
04:17 pm
vtvt
vTv Therapeutics initiated with a Buy at BTIG
Medium
Report
vTv Therapeutics initiated with a Buy at BTIG